109 related articles for article (PubMed ID: 26321712)
1. [Results of a Special Drug Use-Results Survey on Compliance to Tegafur/Uracil(UFT)Adjuvant Chemotherapy for Non-Small Cell Lung Cancer].
Koyama T; Funato Y; Yamaguchi Y; Oda M; Ito K
Gan To Kagaku Ryoho; 2015 Aug; 42(8):973-80. PubMed ID: 26321712
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Wada H; Hitomi S; Teramatsu T
J Clin Oncol; 1996 Apr; 14(4):1048-54. PubMed ID: 8648356
[TBL] [Abstract][Full Text] [Related]
3. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and Efficacy of Sequential Chemotherapy in Patients with p-stage I Non-small Cell Lung Cancer that Recurring during Postoperative Tegafur-Uracil Adjuvant Chemotherapy.
Kashiwabara K; Semba H; Fujii S; Tsumura S
Cancer Invest; 2018; 36(8):424-430. PubMed ID: 30234395
[TBL] [Abstract][Full Text] [Related]
6. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant UFT therapy does not increase survival in people with resected stage 1 non-small cell lung cancer.
Stewart L; Burdett S
Cancer Treat Rev; 2005 Oct; 31(6):487-90. PubMed ID: 16185813
[No Abstract] [Full Text] [Related]
8. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy for non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. The Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy.
Wada H; Tanaka F; Hitomi S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):98-102. PubMed ID: 9348578
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
11. Randomised study of adjuvant chemotherapy for completely resected p-stage I-IIIA non-small cell lung cancer.
Nakagawa K; Tada H; Akashi A; Yasumitsu T; Iuchi K; Taki T; Kodama K;
Br J Cancer; 2006 Oct; 95(7):817-21. PubMed ID: 16969350
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
[TBL] [Abstract][Full Text] [Related]
13. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
Fukushima M; Tsushima T; Ito H; Fukuda Y; Maruyama A; Fujita H; Yagihashi N; Tsuge T; Ishioka T; Kudo T; Kishibe S; Sato T; Machida S; Kogawa R; Takashima K; Koie H; Fujita K
Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
[TBL] [Abstract][Full Text] [Related]
14. [A phase II study of UFT in non-small cell lung cancer].
Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068
[TBL] [Abstract][Full Text] [Related]
15. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer.
Ueda H; Sakada T; Kuwahara M; Motohiro A
Anticancer Drugs; 2004 Jan; 15(1):29-33. PubMed ID: 15090740
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy for non-small cell lung cancer].
Otake Y; Tanaka F; Wada H; Hitomi S
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1245-51. PubMed ID: 9279343
[TBL] [Abstract][Full Text] [Related]
17. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy with oral etoposide, UFT and carboplatin in non-small cell lung cancer].
Kinoshita T; Akaogi E; Mitsui K; Onizuka M; Ishikawa S; Morita R; Ishibashi O; Suga M; Inagaki M; Okazaki H
Gan To Kagaku Ryoho; 1994 May; 21(6):891-4. PubMed ID: 8185351
[No Abstract] [Full Text] [Related]
20. Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: have we made progress?
Feld R
J Clin Oncol; 1996 Apr; 14(4):1045-7. PubMed ID: 8648355
[No Abstract] [Full Text] [Related]
[Next] [New Search]